Literature DB >> 17123105

Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer.

Magali Svrcek, Jacques Cosnes, Emmanuel Tiret, Malika Bennis, Yann Parc, Jean-François Fléjou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17123105     DOI： 10.1007/s00428-006-0338-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  6 in total

1.  Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system.

Authors:  N S Goldstein; M Armin
Journal:  Cancer       Date:  2001-09-01       Impact factor: 6.860

Review 2.  Epidermal growth factor receptor-targeted therapy in colorectal cancer.

Authors:  Peter J O'dwyer; Al B Benson
Journal:  Semin Oncol       Date:  2002-10       Impact factor: 4.929

3.  Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

Authors:  Ki Young Chung; Jinru Shia; Nancy E Kemeny; Manish Shah; Gary K Schwartz; Archie Tse; Audrey Hamilton; Dorothy Pan; Deborah Schrag; Lawrence Schwartz; David S Klimstra; Daniel Fridman; David P Kelsen; Leonard B Saltz
Journal:  J Clin Oncol       Date:  2005-01-27       Impact factor: 44.544

4.  Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease.

Authors:  R J Alexander; A Panja; E Kaplan-Liss; L Mayer; R F Raicht
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

5.  Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

Authors:  David Cunningham; Yves Humblet; Salvatore Siena; David Khayat; Harry Bleiberg; Armando Santoro; Danny Bets; Matthias Mueser; Andreas Harstrick; Chris Verslype; Ian Chau; Eric Van Cutsem
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

Review 6.  Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs.

Authors:  F Ciardiello; Giampaolo Tortora
Journal:  Eur J Cancer       Date:  2003-07       Impact factor: 9.162
  6 in total
  10 in total

1.  Epidermal growth factor receptor inhibits colitis-associated cancer in mice.

Authors:  Philip E Dubé; Fang Yan; Shivesh Punit; Nandini Girish; Steven J McElroy; M Kay Washington; D Brent Polk
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

Review 2.  Molecular basis of the potential of mesalazine to prevent colorectal cancer.

Authors:  Carmine Stolfi; Roberto Pellegrini; Eleonora Franze; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

3.  Loss of RHBDF2 results in an early-onset spontaneous murine colitis.

Authors:  Ramasatyaveni Geesala; Willow Schanz; Mikayla Biggs; Garima Dixit; Joseph Skurski; Prajwal Gurung; David K Meyerholz; David Elliott; Priya D Issuree; Thorsten Maretzky
Journal:  J Leukoc Biol       Date:  2019-01-29       Impact factor: 4.962

4.  Radiographic and endoscopic regression of metastatic gastric cancer to the colon in the setting of 5-aminosalicylic acid use.

Authors:  Yuval A Patel; Shannon J McCall; Xuefeng Zhang; Tracy Jaffe; Rahul A Shimpi
Journal:  J Gastrointest Oncol       Date:  2016-12

Review 5.  CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract.

Authors:  Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

6.  Macrophage migration inhibitory factor and interleukin-8 produced by gastric epithelial cells during Helicobacter pylori exposure induce expression and activation of the epidermal growth factor receptor.

Authors:  Ellen J Beswick; Victor E Reyes
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

Review 7.  Colorectal cancer chemoprevention by mesalazine and its derivatives.

Authors:  Carmine Stolfi; Francesco Pallone; Giovanni Monteleone
Journal:  J Biomed Biotechnol       Date:  2012-06-04

8.  Combination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell lines.

Authors:  Mona M Saber; May A Galal; Afaf A Ain-Shoka; Samia A Shouman
Journal:  BMC Cancer       Date:  2016-02-19       Impact factor: 4.430

9.  Use of aspirin in the prevention of colorectal cancer through TIGIT-CD155 pathway.

Authors:  Bin Ma; Xiangguo Duan; Qiunan Zhou; Juanxi Liu; Xiaojuan Yang; Dong Zhang; Shaoqi Yang; Yong Du; Hai Li; Chunxia Su
Journal:  J Cell Mol Med       Date:  2019-05-14       Impact factor: 5.310

10.  An EGFR targeted PET imaging probe for the detection of colonic adenocarcinomas in the setting of colitis.

Authors:  N Selcan Turker; Pedram Heidari; Raju Kucherlapati; Melanie Kucherlapati; Umar Mahmood
Journal:  Theranostics       Date:  2014-07-01       Impact factor: 11.556
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.